| Product Code: ETC9406231 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Korea Irritable Bowel Syndrome Treatment Market Overview |
3.1 South Korea Country Macro Economic Indicators |
3.2 South Korea Irritable Bowel Syndrome Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 South Korea Irritable Bowel Syndrome Treatment Market - Industry Life Cycle |
3.4 South Korea Irritable Bowel Syndrome Treatment Market - Porter's Five Forces |
3.5 South Korea Irritable Bowel Syndrome Treatment Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 South Korea Irritable Bowel Syndrome Treatment Market Revenues & Volume Share, By Product, 2021 & 2031F |
4 South Korea Irritable Bowel Syndrome Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis rates of irritable bowel syndrome (IBS) in South Korea |
4.2.2 Growing demand for effective and innovative IBS treatments |
4.2.3 Advancements in medical research leading to new treatment options for IBS patients |
4.3 Market Restraints |
4.3.1 High cost associated with IBS treatments limiting accessibility for some patients |
4.3.2 Lack of reimbursement options for certain IBS treatment modalities |
4.3.3 Presence of alternative therapies and traditional medicine impacting the adoption of conventional IBS treatments |
5 South Korea Irritable Bowel Syndrome Treatment Market Trends |
6 South Korea Irritable Bowel Syndrome Treatment Market, By Types |
6.1 South Korea Irritable Bowel Syndrome Treatment Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 South Korea Irritable Bowel Syndrome Treatment Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 South Korea Irritable Bowel Syndrome Treatment Market Revenues & Volume, By IBS-C, 2021- 2031F |
6.1.4 South Korea Irritable Bowel Syndrome Treatment Market Revenues & Volume, By IBS-D, 2021- 2031F |
6.2 South Korea Irritable Bowel Syndrome Treatment Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 South Korea Irritable Bowel Syndrome Treatment Market Revenues & Volume, By Xifaxan, 2021- 2031F |
6.2.3 South Korea Irritable Bowel Syndrome Treatment Market Revenues & Volume, By Linzess/Constella, 2021- 2031F |
6.2.4 South Korea Irritable Bowel Syndrome Treatment Market Revenues & Volume, By Viberzi, 2021- 2031F |
6.2.5 South Korea Irritable Bowel Syndrome Treatment Market Revenues & Volume, By Amitiza, 2021- 2031F |
6.2.6 South Korea Irritable Bowel Syndrome Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 South Korea Irritable Bowel Syndrome Treatment Market Import-Export Trade Statistics |
7.1 South Korea Irritable Bowel Syndrome Treatment Market Export to Major Countries |
7.2 South Korea Irritable Bowel Syndrome Treatment Market Imports from Major Countries |
8 South Korea Irritable Bowel Syndrome Treatment Market Key Performance Indicators |
8.1 Patient adherence rate to prescribed IBS treatment regimens |
8.2 Number of clinical trials and research studies conducted on new IBS treatment approaches |
8.3 Rate of adoption of emerging technologies in the diagnosis and treatment of IBS |
9 South Korea Irritable Bowel Syndrome Treatment Market - Opportunity Assessment |
9.1 South Korea Irritable Bowel Syndrome Treatment Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 South Korea Irritable Bowel Syndrome Treatment Market Opportunity Assessment, By Product, 2021 & 2031F |
10 South Korea Irritable Bowel Syndrome Treatment Market - Competitive Landscape |
10.1 South Korea Irritable Bowel Syndrome Treatment Market Revenue Share, By Companies, 2024 |
10.2 South Korea Irritable Bowel Syndrome Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |